Open an account

Humana

HUM · NYSE

$427.38+$12.40 (+2.99%)TodayMarket closed ·
Prev close $414.98

About HUM

Humana Inc. engages in the provision of health insurance services. The company is headquartered in Louisville, Kentucky and currently employs 67,060 full-time employees. The firm's segments include Insurance and CenterWell. The Insurance segment consists of Medicare benefits, marketed to individuals or directly via group Medicare accounts, as well as its contract with CMS to administer the Limited Income Newly Eligible Transition (LI-NET) prescription drug plan program and contracts with various states to provide Medicaid, dual eligible demonstration, and Long-Term Support Services benefits. This segment also includes products consisting of employer group commercial fully-insured medical and specialty health insurance benefits marketed to individuals and employer groups. The CenterWell segment includes its pharmacy, primary care, and home solutions operations. The segment also includes its strategic partnerships with WCAS to develop and operate senior-focused, payor-agnostic, primary care centers, as well as its minority ownership interest in hospice operations.

Employees
67,060
Headquarters
Louisville, Kentucky
Listed
May 18, 1971
Sector
Health Care
Industry
Health Care Providers & Services
Website
humana.com

HUM key statistics

Market cap
51.32B
Price-earnings ratio
39.19
Dividend yield
0.84%
Average volume
1.59M
Volume
2.01M
Open price
$416.50
High today
$430.32
Low today
$416.50
52 Week high
$456.50
52 Week low
$163.11

Humana (HUM) at a glance

As of Oct 20, 2026, Humana (HUM) shares are priced at $427.38, giving the company a market cap of 51.32B, a price-to-earnings ratio of 39.19 and a dividend yield of 0.84%.

Today the stock has traded between $416.50 and $430.32. The current price is 2.6% above the day's low and 0.7% below its high.

Volume so far is 2.01M shares, above the average of 1.59M shares a day.

Over the past year Humana has ranged from $163.11 to $456.50, and now sits 90% of the way up that range.

Humana met or beat analyst EPS estimates in 8 of the last 8 quarters. In Q2 FY26 it reported $7.61 per share against an estimate of $7.29.

The average analyst price target is $429.06, 0.4% above the current price, from 20 recent ratings.

Analyst ratings

Latest rating from each analyst over the past 12 months

55%of 20 analyst ratings say Buy
  • Buy55.0%
  • Hold40.0%
  • Sell5.0%
Price target · 28 analystsAvg $429.06
Low
$282.80
Now
$427.38
High
$540.75

HUM earnings

Earnings per share, reported against the analyst estimate

Beat the estimate in 8 of the last 8 quarters, by 7.7% on average.

  1. Q3 FY24: reported $4.16 per share against an estimate of $3.44
  2. Q4 FY24: reported -$2.16 per share against an estimate of -$2.19
  3. Q1 FY25: reported $11.58 per share against an estimate of $10.17
  4. Q2 FY25: reported $6.27 per share against an estimate of $5.98
  5. Q3 FY25: reported $3.24 per share against an estimate of $2.85
  6. Q4 FY25: reported -$3.96 per share against an estimate of -$4.05
  7. Q1 FY26: reported $10.31 per share against an estimate of $10.29
  8. Q2 FY26: reported $7.61 per share against an estimate of $7.29

HUM news

  • Press releaseGlobe Newswire

    The Future of Healthcare: AI-Powered, Coordinated and Proactive Care

  • Erica Kollmann

    QUICK SPARK: UnitedHealth Calls 2026 the Bottom for Medicaid Margins

  • Press releasePRNewswire

    Did Humana Inc. Insiders Breach their Fiduciary Duties to Shareholders?

  • Press releaseBusiness Wire

    Humana Announces New Strategic Joint Venture with BlackRock to Manage CenterWell Senior Primary Care Clinics

  • Press releaseBusiness Wire

    Humana Inc. to Release Third Quarter 2026 Results on November 6, 2026

  • Vandana Singh

    DataMeds AI Stock Rises After Humana Adds Medicaid Coverage for ChemoFx Cancer Test

  • Press releasePRNewswire

    After a Record-Setting Week, Wall Street Turns to Inflation Data and the First Big Earnings Reports

  • Piero Cingari

    Stock Market Today: Nasdaq 100 Rebounds From OpenAI Scare, T-Mobile Tumbles 12%

Similar companies

Companies in the same industry as Humana

Most active stocks

Highest trading volume today

Newly listed

Companies that went public in the past six weeks

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.